Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up

Background: Invasive lobular carcinoma (ILC) comprises 8–15 % of all invasive breast cancers and large population-based studies with >10 years of follow-up are rare. Whether ILC has a long-time prognosis different from that of invasive ductal carcinoma, (IDC) remains controversial. Purpose: To in...

Full description

Bibliographic Details
Main Authors: C. Chamalidou, H. Fohlin, P. Albertsson, L.-G. Arnesson, Z. Einbeigi, E. Holmberg, A. Nordenskjöld, B. Nordenskjöld, P. Karlsson, B. Linderholm
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621004203
_version_ 1819099379908214784
author C. Chamalidou
H. Fohlin
P. Albertsson
L.-G. Arnesson
Z. Einbeigi
E. Holmberg
A. Nordenskjöld
B. Nordenskjöld
P. Karlsson
B. Linderholm
author_facet C. Chamalidou
H. Fohlin
P. Albertsson
L.-G. Arnesson
Z. Einbeigi
E. Holmberg
A. Nordenskjöld
B. Nordenskjöld
P. Karlsson
B. Linderholm
author_sort C. Chamalidou
collection DOAJ
description Background: Invasive lobular carcinoma (ILC) comprises 8–15 % of all invasive breast cancers and large population-based studies with >10 years of follow-up are rare. Whether ILC has a long-time prognosis different from that of invasive ductal carcinoma, (IDC) remains controversial. Purpose: To investigate the excess mortality rate ratio (EMRR) of patients with ILC and IDC and to correlate survival with clinical parameters in a large population-based cohort. Material and methods: From 1989 through 2006, we identified 17,481 patients diagnosed with IDC (n = 14,583) or ILC (n = 2898), younger than 76 years from two Swedish Regional Cancer Registries. Relative survival (RS) during 20 years of follow up was analysed. Results: ILC was significantly associated with older age, larger tumours, ER positivity and well differentiated tumours. We noticed an improved survival for patients with ILC during the first five years, excess mortality rate ratio (EMRR) 0.64 (CI 95 % 0.53–0.77). This was shifted to a significant decreased survival 10–15 years after diagnosis (EMRR 1.49, CI 95 % 1.16–1.93). After 20 years the relative survival rates were similar, 0.72 for ILC and 0.73 for IDC. Conclusions: During the first five years after surgery, the EMRR was lower for patients with ILC as compared to patients with IDC, but during the years 10–15 after surgery, we observed an increased EMRR for patients with ILC as compared to IDC. These EMRR between ILC and IDC were statistically significant but the absolute difference in excess mortality between the two groups was small.
first_indexed 2024-12-22T00:45:57Z
format Article
id doaj.art-6e374d48a2e941ee82c311dcfd233ea2
institution Directory Open Access Journal
issn 1532-3080
language English
last_indexed 2024-12-22T00:45:57Z
publishDate 2021-10-01
publisher Elsevier
record_format Article
series Breast
spelling doaj.art-6e374d48a2e941ee82c311dcfd233ea22022-12-21T18:44:33ZengElsevierBreast1532-30802021-10-0159294300Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow upC. Chamalidou0H. Fohlin1P. Albertsson2L.-G. Arnesson3Z. Einbeigi4E. Holmberg5A. Nordenskjöld6B. Nordenskjöld7P. Karlsson8B. Linderholm9Institution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden; Department of Oncology, Skaraborg Hospital, Skövde, Sweden; Corresponding author. Institution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.Regional Cancer Center of Southeast Sweden, Linköping University Hospital, Linköping, Sweden; Department of Biomedical and Clinical Sciences, Medical Faculty, Linköping University, SwedenInstitution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Biomedical and Clinical Sciences, Medical Faculty, Linköping University, SwedenInstitution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden; Department of Oncology, Södra Älvsborgs Hospital, Borås, SwedenRegional Cancer Centre of Western Sweden, Sahlgrenska University Hospital, Gothenburg, Sweden; Institution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg, SwedenDepartment of Oncology, Södra Älvsborgs Hospital, Borås, SwedenRegional Cancer Center of Southeast Sweden, Linköping University Hospital, Linköping, SwedenInstitution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, SwedenInstitution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, SwedenBackground: Invasive lobular carcinoma (ILC) comprises 8–15 % of all invasive breast cancers and large population-based studies with >10 years of follow-up are rare. Whether ILC has a long-time prognosis different from that of invasive ductal carcinoma, (IDC) remains controversial. Purpose: To investigate the excess mortality rate ratio (EMRR) of patients with ILC and IDC and to correlate survival with clinical parameters in a large population-based cohort. Material and methods: From 1989 through 2006, we identified 17,481 patients diagnosed with IDC (n = 14,583) or ILC (n = 2898), younger than 76 years from two Swedish Regional Cancer Registries. Relative survival (RS) during 20 years of follow up was analysed. Results: ILC was significantly associated with older age, larger tumours, ER positivity and well differentiated tumours. We noticed an improved survival for patients with ILC during the first five years, excess mortality rate ratio (EMRR) 0.64 (CI 95 % 0.53–0.77). This was shifted to a significant decreased survival 10–15 years after diagnosis (EMRR 1.49, CI 95 % 1.16–1.93). After 20 years the relative survival rates were similar, 0.72 for ILC and 0.73 for IDC. Conclusions: During the first five years after surgery, the EMRR was lower for patients with ILC as compared to patients with IDC, but during the years 10–15 after surgery, we observed an increased EMRR for patients with ILC as compared to IDC. These EMRR between ILC and IDC were statistically significant but the absolute difference in excess mortality between the two groups was small.http://www.sciencedirect.com/science/article/pii/S0960977621004203Relative survival rateExcess mortality rate ratioLobular breast cancerDuctal breast cancer
spellingShingle C. Chamalidou
H. Fohlin
P. Albertsson
L.-G. Arnesson
Z. Einbeigi
E. Holmberg
A. Nordenskjöld
B. Nordenskjöld
P. Karlsson
B. Linderholm
Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up
Breast
Relative survival rate
Excess mortality rate ratio
Lobular breast cancer
Ductal breast cancer
title Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up
title_full Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up
title_fullStr Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up
title_full_unstemmed Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up
title_short Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up
title_sort survival patterns of invasive lobular and invasive ductal breast cancer in a large population based cohort with two decades of follow up
topic Relative survival rate
Excess mortality rate ratio
Lobular breast cancer
Ductal breast cancer
url http://www.sciencedirect.com/science/article/pii/S0960977621004203
work_keys_str_mv AT cchamalidou survivalpatternsofinvasivelobularandinvasiveductalbreastcancerinalargepopulationbasedcohortwithtwodecadesoffollowup
AT hfohlin survivalpatternsofinvasivelobularandinvasiveductalbreastcancerinalargepopulationbasedcohortwithtwodecadesoffollowup
AT palbertsson survivalpatternsofinvasivelobularandinvasiveductalbreastcancerinalargepopulationbasedcohortwithtwodecadesoffollowup
AT lgarnesson survivalpatternsofinvasivelobularandinvasiveductalbreastcancerinalargepopulationbasedcohortwithtwodecadesoffollowup
AT zeinbeigi survivalpatternsofinvasivelobularandinvasiveductalbreastcancerinalargepopulationbasedcohortwithtwodecadesoffollowup
AT eholmberg survivalpatternsofinvasivelobularandinvasiveductalbreastcancerinalargepopulationbasedcohortwithtwodecadesoffollowup
AT anordenskjold survivalpatternsofinvasivelobularandinvasiveductalbreastcancerinalargepopulationbasedcohortwithtwodecadesoffollowup
AT bnordenskjold survivalpatternsofinvasivelobularandinvasiveductalbreastcancerinalargepopulationbasedcohortwithtwodecadesoffollowup
AT pkarlsson survivalpatternsofinvasivelobularandinvasiveductalbreastcancerinalargepopulationbasedcohortwithtwodecadesoffollowup
AT blinderholm survivalpatternsofinvasivelobularandinvasiveductalbreastcancerinalargepopulationbasedcohortwithtwodecadesoffollowup